Aim to launch around 30 products every year in India- Glenmark

(2:35)

Sujesh Vasu Devan Glenmark Pharma | Globally - Researched Anti - Diabetes Drug Remogliflozin launch

(3:12)

Glenmark launches antiviral drug Favipiravir for COVID -19

(5:14)

Glenmark launches COVID-19 drug in India | Coronavirus Pandemic | WION News

(1:41)

Glenmark Pharma Launches Novel, Globally - Researched Anti - Diabetes Drug Remogliflozin in India

(12:12)

First Nasal Spray For Covid-19 Treatment In India Glenmark’s FabiSpray Launched | Made In India

(1:32)

Glenmark receives approval to launch Favipiravir (FabiFlu®) for COVID-19 patients

(22:46)

H2 Margins Is Expected To Be Better Given The Respiratory Launches: Glenmark Pharma | CNBC TV18

(7:34)

Novo Nordisk CEO Lars Fruergaard Jørgensen on Q4 results, Wegovy demand and drug pipeline outlook

(7:56)

Tech Lifts Hong Kong Stocks to Three-Month High | Bloomberg: The China Show 2/7/2025

(1:32:33)

Google Stocks Tank, OpenAI to Make Super Bowl Ad Debut | Vantage with Palki Sharma | N18G

(5:38)

Glenmark Launches #Covid19 Drug At Rs 103 A Tablet

(2:39)

Glenmark Pharma Presents First Clinical Data From Phase 1 Study For Oncology/Cancer Drug ISB 2001

(1:24)

Glenmark launches antiviral drug Favipiravir; ICMR approves Remdesivir under EUA | TOP Headlines

(1:40)

COVID 19 Glenmark Launches FabiSpray In India

(1:25)

Expect The Core Business Growth In FY17 To Be Around 15%: Glenmark

(1:13)

Glenmark loses patent case to Abbott in US; stock tumbles

(2:24)

Glenmark Launches Anti-Diabetes Drug Remogliflozin In India | Hyderabad | V6 News

(1:24)

Aim To Deliver The First Biologic In 2021: Glenmark Pharma

(1:48)

See Mid Single Digit Growth For US Business | VS Mani, Glenmark Pharma Explains | ET Now

(8:14)

Glenmark revives IPO plans

(2:6)

Glenmark Pharma: R\u0026D unit monetization plans move ahead

(3:10)

Glenmark Pharma Q1FY25: Co Posts Double-Digit Growth In India \u0026 Europe, Margin Improves | CNBC TV18

(2:7)

Sensex closes 180 points up, Glenmark Pharma jumps 27 pc

(1:16)

Glenmark Pharmaceuticals Limited Q1 FY23 Earnings Concall

(50:55)